UK moving towards next level out of lockdown, says Indian-origin minister

Image
Press Trust of India London
Last Updated : May 18 2020 | 5:15 PM IST

The UK is in a position to move to the next level of its COVID-19 response and further lift the lockdown measures in place in careful steps, UK Business Secretary Alok Sharma has said.

The Indian-origin minister said the country had succeeded in keeping the rate of infection, so-called R rate, and therefore on track to hit Level 3 in its five-level strategy to ease out of the lockdown set by the government.

The alert level is based primarily on the R value and the number of coronavirus cases. And in turn, that alert level will determine the level of social distancing measures in place the lower the level, the fewer the measures; the higher the level, the stricter the measures, Sharma said during the daily Downing Street briefing in London on Sunday evening.

Throughout the period of lockdown, which started on March 23, we have been at Level 4. Thanks to you, people across the country, we have collectively helped to bring the R level down. And we are now in a position to begin moving to Level 3, in careful steps, he said.

The minister unveiled a new 93-million pounds investment to accelerate the UK's first Vaccines Manufacturing Innovation Centre, which is set to be completed by next year.

While the centre is being built, the government will establish a rapid deployment facility thanks to a further investment of 38 million pounds to begin coronavirus vaccine manufacturing at scale within months, ready in time for when a vaccine is discovered.

This facility will support efforts to ensure a vaccine is widely available to the UK public as soon as possible. In total, the government has now committed over a quarter of a billion pounds towards developing a vaccine in the UK, he said.

While there are currently no drugs in the world that have been clinically proven to treat coronavirus, he said the UK government is working with scientists and medical experts to identify promising candidates.

In spite of the tireless effort of our scientists, it is possible that we may never find a successful coronavirus vaccine. So we also need to look at other drug treatments and therapeutics for those who get the virus, he said.

His announcement came as the official figures confirm that of those who tested positive for coronavirus across hospitals and all other settings in the UK, 34,636 have now died of the deadly virus in the country.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 18 2020 | 5:15 PM IST

Next Story